Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Gromada

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Cellular Signalling|March 10, 2018
Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic β-cellsSubu Surendran Rajasekaran, Jaeyoon Kim, Gian-Carlo Gaboardi, et al.
Diabetes|December 15, 2019
Clinical and Molecular Prevalence of Lipodystrophy in an Unascertained Large Clinical Care CohortClaudia Gonzaga-Jauregui, Wenzhen Ge, Jeffrey Staples, et al.
Journal of Lipid Research|July 11, 2020
Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearanceRene C Adam, Ivory J Mintah, Corey A Alexa-Braun, et al.
Communications Biology|August 2, 2022
Reduced calcium levels and accumulation of abnormal insulin granules in stem cell models of HNF1A deficiencyBryan J González, Haoquan Zhao, Jacqueline Niu, et al.
The Journal of Clinical Investigation|May 20, 2005
FGF-21 as a novel metabolic regulatorAlexei Kharitonenkov, Tatiyana L Shiyanova, Anja Koester, et al.
Nature Medicine|November 1, 2011
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cellsHelga Ellingsgaard, Irina Hauselmann, Beat Schuler, et al.
Cell|October 14, 2004
Removal of Ca2+ channel beta3 subunit enhances Ca2+ oscillation frequency and insulin exocytosisPer-Olof Berggren, Shao-Nian Yang, Manabu Murakami, et al.
The Journal of Clinical Investigation|June 3, 2004
Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitorsKyle W Sloop, Julia Xiao-Chun Cao, Angela M Siesky, et al.
The New England Journal of Medicine|March 3, 2016
Inactivating Variants in ANGPTL4 and Risk of Coronary Artery DiseaseFrederick E Dewey, Viktoria Gusarova, Colm O'Dushlaine, et al.
Science Translational Medicine|November 22, 2023
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiencyJudith Y Altarejos, Jeffrey Pangilinan, Simona Podgrabinska, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Cellular Signalling|March 10, 2018
Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic β-cellsSubu Surendran Rajasekaran, Jaeyoon Kim, Gian-Carlo Gaboardi, et al.
Diabetes|December 15, 2019
Clinical and Molecular Prevalence of Lipodystrophy in an Unascertained Large Clinical Care CohortClaudia Gonzaga-Jauregui, Wenzhen Ge, Jeffrey Staples, et al.
Journal of Lipid Research|July 11, 2020
Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearanceRene C Adam, Ivory J Mintah, Corey A Alexa-Braun, et al.
Communications Biology|August 2, 2022
Reduced calcium levels and accumulation of abnormal insulin granules in stem cell models of HNF1A deficiencyBryan J González, Haoquan Zhao, Jacqueline Niu, et al.
The Journal of Clinical Investigation|May 20, 2005
FGF-21 as a novel metabolic regulatorAlexei Kharitonenkov, Tatiyana L Shiyanova, Anja Koester, et al.
Nature Medicine|November 1, 2011
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cellsHelga Ellingsgaard, Irina Hauselmann, Beat Schuler, et al.
Cell|October 14, 2004
Removal of Ca2+ channel beta3 subunit enhances Ca2+ oscillation frequency and insulin exocytosisPer-Olof Berggren, Shao-Nian Yang, Manabu Murakami, et al.
The Journal of Clinical Investigation|June 3, 2004
Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitorsKyle W Sloop, Julia Xiao-Chun Cao, Angela M Siesky, et al.
The New England Journal of Medicine|March 3, 2016
Inactivating Variants in ANGPTL4 and Risk of Coronary Artery DiseaseFrederick E Dewey, Viktoria Gusarova, Colm O'Dushlaine, et al.
Science Translational Medicine|November 22, 2023
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiencyJudith Y Altarejos, Jeffrey Pangilinan, Simona Podgrabinska, et al.
Pageof 11